Gene · 84444
Papers2,742
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
241 to 260 of 2,742
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Decoding Diffuse Midline Gliomas: A Comprehensive Review of Pathogenesis, Diagnosis and Treatment. | Cancers (Basel) | 2023 | 37835563 | PubTator, text mining | PubMed |
| Epigenetic Modulators as Therapeutic Agents in Cancer. | Int J Mol Sci | 2023 | 37834411 | PubTator, text mining | PubMed |
| Unusual Presentation of SET::NUP214-Associated Concomitant Hematological Neoplasm in a Child-Diagnostic and Treatment Struggle. | Int J Mol Sci | 2023 | 37833906 | PubTator, text mining | PubMed |
| Rare de novo gain-of-function missense variants in DOT1L are associated with developmental delay and congenital anomalies. | Am J Hum Genet | 2023 | 37827158 | Swiss-Prot, curated | PubMed |
| Advancing Diagnostics and Therapy to Reach Universal Cure in Childhood ALL. | J Clin Oncol | 2023 | 37820294 | PubTator, text mining | PubMed |
| Next-Generation Sequencing Analysis of 3 Uterine Adenosarcomas with Heterogeneously Differentiated Genomic Mutations. | Int J Anal Chem | 2023 | 37810911 | PubTator, text mining | PubMed |
| Epigenetic targeting to enhance acute myeloid leukemia-directed immunotherapy. | Front Immunol | 2023 | 37809078 | PubTator, text mining | PubMed |
| [Acute myeloid leukemia with positive PICAML-MLLT10 fusion gene: report of 4 cases and literature review]. | Zhonghua Xue Ye Xue Za Zhi | 2023 | 37803846 | PubTator, text mining | PubMed |
| Acute myeloid leukemia: from NGS, through scRNA-seq, to CAR-T. dissect cancer heterogeneity and tailor the treatment. | J Exp Clin Cancer Res | 2023 | 37803464 | PubTator, text mining | PubMed |
| Predictive value of DOT1L mutations for clinical outcomes in non-small-cell lung cancer patients receiving immune checkpoint inhibitor therapy. | Clin Transl Med | 2023 | 37784247 | PubTator, text mining | PubMed |
| Exploring the dynamic interplay between cancer stem cells and the tumor microenvironment: implications for novel therapeutic strategies. | J Transl Med | 2023 | 37784157 | PubTator, text mining | PubMed |
| Premature senescence and cardiovascular disease following cancer treatments: mechanistic insights. | Front Cardiovasc Med | 2023 | 37781317 | PubTator, text mining | PubMed |
| Cla4 phosphorylates histone methyltransferase Set1 to prevent its degradation by the APC/CCdh1 complex. | Sci Adv | 2023 | 37774018 | PubTator, text mining | PubMed |
| Synthesis of ubiquitinated proteins for biochemical and functional analysis. | Chem Sci | 2023 | 37772107 | PubTator, text mining | PubMed |
| RNF40 epigenetically modulates glycolysis to support the aggressiveness of basal-like breast cancer. | Cell Death Dis | 2023 | 37770435 | PubTator, text mining | PubMed |
| Nucleophosmin 1 cooperates with the methyltransferase DOT1L to preserve peri-nucleolar heterochromatin organization by regulating H3K27me3 levels and DNA repeats expression. | Epigenetics Chromatin | 2023 | 37759327 | PubTator, text mining | PubMed |
| Histone Methyltransferases as a New Target for Epigenetic Action of Vorinostat. | Biochemistry (Mosc) | 2023 | 37751867 | PubTator, text mining | PubMed |
| Modelling acquired resistance to DOT1L inhibition exhibits the adaptive potential of KMT2A-rearranged acute lymphoblastic leukemia. | Exp Hematol Oncol | 2023 | 37740239 | PubTator, text mining | PubMed |
| The human leukemic oncogene MLL-AF4 promotes hyperplastic growth of hematopoietic tissues in Drosophila larvae. | iScience | 2023 | 37720104 | PubTator, text mining | PubMed |
| A novel NET-related gene signature for predicting DLBCL prognosis. | J Transl Med | 2023 | 37716978 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/84444/papers?page=13